Intercept Pharmaceuticals
Alfasigma Specialty Pharmaceuticals is committed to developing and delivering novel medicines for people living with rare and serious liver diseases.
Why it's on the radar
TeamFundraising signals (who's likely raising, and why) are on Team.Start a free 14-day trial →Funding history · 0 rounds
No rounds on record yet.
Key people
ProKey people, exec moves and open roles are on Pro.Start a free 14-day trial →